S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY

• V. Minard-Colin,
• J. Buechner,
• F. Locatelli,
• B. Gonzalez Martinez,
• B. J. Vormoor,
• S. Cooper,
• J. Krueger,
• S. Napolitano,
• A. Attarbaschi,
• A. Baruchel,
• S. Ghorashian,
• M. L. Hermiston,
• H. Hiramatsu,
• M. Ifversen,
• S. John,
• S. L. Khaw,
• T. A. O’Brien,
• C. L. Phillips,
• C. Diaz de Heredia,
• D. Tomizawa,
• K. Vettenranta,
• A. S. Wayne,
• S. Newsome,
• R. Awasthi,
• S. Redondo,
• A. Masood,
• S. L. Maude,
• B. Burkhardt

Affiliations

V. Minard-Colin

1 Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France

J. Buechner

2 Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway

F. Locatelli

3 Department of Pediatric Hematology and Oncology, IRCCS Ospedale Bambino Gesù Children’s Hospital, Sapienza, University of Rome, Rome, Italy

B. Gonzalez Martinez

4 Hospital Universitario La Paz, Madrid, Spain

B. J. Vormoor

5 Prinses Maxima Centrum, Utrecht, Netherlands

S. Cooper

6 Johns Hopkins Comprehensive Cancer Center, Baltimore, MD, United States of America

J. Krueger

7 Division of Haematology/Oncology/Bone Marrow Transplantation, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada

S. Napolitano

8 Hematology-Oncology and Bone Marrow Transplantation Unit, Pediatric Department, and Monza and Brianza Foundation for Children and their Mums, San Gerardo Hospital, Lombardia, Monza, Italy

A. Attarbaschi

9 St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria

A. Baruchel

10 University Hospital Robert Debré (APHP) and Université de Paris, Paris, France

S. Ghorashian

11 Great Ormond Street Hospital for Children NHS Trust Haematology Department, London, United Kingdom

M. L. Hermiston

12 University of California San Francisco Benioff Children’s Hospital, San Francisco, CA, United States of America

H. Hiramatsu

13 Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

M. Ifversen

14 Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

S. John

15 University of Texas Southwestern Medical Center, Dallas, TX, United States of America

S. L. Khaw

16 Children’s Cancer Centre, Royal Children’s Hospital and Murdoch Children’s Research Institute, Parkville, VIC

T. A. O’Brien

17 Kids Cancer Centre, Sydney Children’s Hospital, Randwick, NSW, Australia

C. L. Phillips

18 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States of America

C. Diaz de Heredia

19 Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca, Barcelona, Spain

D. Tomizawa

20 Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan

K. Vettenranta

21 University of Helsinki, Helsinki, Finland

A. S. Wayne

22 Children’s Hospital Los Angeles, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America

S. Newsome

23 Novartis Pharma AG, Basel, Switzerland

R. Awasthi

24 Novartis Pharmaceutical Corporation, East Hanover, NJ, United States of America

S. Redondo

25 Novartis Farmaceutica S.A., Madrid, Spain

A. Masood

24 Novartis Pharmaceutical Corporation, East Hanover, NJ, United States of America

S. L. Maude

26 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America

B. Burkhardt

27 Pediatric Haematology and Oncology, University Hospital Muenster, Muenster, Germany